WBSCR22 confers oxaliplatin resistance in human colorectal cancerDongmei Yan(Zhejiang Academy of Medical Sciences), Xiaoju Wang(Zhejiang Academy of Medical Sciences)Scientific ReportsNovember 7, 201710.1038/s41598-017-15749-zCited by 49SaveCiteExport RISWatch citationsRelated PapersKnockdown of Merm1/Wbscr22 attenuates sensitivity of H460 non-small cell lung cancer cells to SN-38 and 5-FU without alteration to p53 expression levels|Molecular Medicine Reports|2014|7